Analyst Ratings for BioCryst Pharma (BCRX)
BCRX Rating Summary
BCRX Price Target Summary
- Highest: $32.00 (H.C. Wainwright)
- Lowest: $9.00 (Barclays)
- Average: $20.70
* Over Last 12-Mos
Overall Rating:
BUY
Rating Trend:
Avg. $ Target:
$20.70 (+137.9%)
* Over Last 12-Mos
Rating Score: 8.2 / 10
Percentile Rank: 85%
Avg. $ Target:
$20.70 (+137.9%)
* Over Last 12-Mos
Rating Score: 8.2 / 10
Percentile Rank: 85%
| Date | Firm | Analyst | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|---|
| 2/18/2026 | Evercore ISI | Gavin Clark-Gartner | New Coverage | Outperform (N/A) |
17.00 (N/A) |
6.95 (8.70) |
25.18% | Details |
| 10/15/2025 | TD Cowen » Updated 2/26/2026 |
Stacy Ku | New Coverage | Buy (N/A) |
30.00 (N/A) |
7.04 (8.70) |
23.58% | Details |
 |
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
